Corticotropin-Releasing Effect of Hexarelin, a Peptidyl GH Secretagogue, in Normal Subjects Pretreated with Metyrapone or RU-486, a Glucocorticoid Receptor Antagonist, and in Patients with Addison’s Disease

Publisher： Karger

E-ISSN： 1423-0194|70|3|200-206

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.70, Iss.3, 1999-09, pp. : 200-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Corticotropin-Releasing Hormone Receptor Expression on Normal and Tumorous Human Adrenocortical Cells

By  

Neuroendocrinology, Vol. 82, Iss. 5-6, 2006-05 ,pp. : 274-281

Karger

Access to resources Recommend Favorite

Liquorice, Growth Retardation and Addison’s Disease

By  

Hormone Research in Paediatrics, Vol. 52, Iss. 5, 2000-05 ,pp. : 253-255

Karger

Access to resources Recommend Favorite

Effect of Antalarmin, a Novel Corticotropin-Releasing Hormone Antagonist, on the Dynamic Function of the Preterm Ovine Fetal Hypothalamo-Pituitary-Adrenal Axis

By  

Neuroendocrinology, Vol. 76, Iss. 1, 2002-07 ,pp. : 47-54

Karger

Access to resources Recommend Favorite

Relation between Corticotropin-Releasing Hormone Neuron Number in the Hypothalamic Paraventricular Nucleus and Depressive State in Alzheimer’s Disease

By  

Neuroendocrinology, Vol. 85, Iss. 1, 2007-03 ,pp. : 37-44

Karger

Access to resources Recommend Favorite

Adrenoleukodystrophy: The Most Frequent Genetic Cause of Addison’s Disease

By  

Hormone Research in Paediatrics, Vol. 59, Iss. 1, 2004-11 ,pp. : 104-105

Karger

Access to resources Recommend Favorite